PROPHYLACTIC USE OF 17OH PROGESTERONE FOR PREVENTION OF PRETERM LABOUR IS EFFECTIVE

PROPHYLACTIC USE OF 17OH PROGESTERONE FOR PREVENTION OF PRETERM LABOUR IS EFFECTIVE

Objective: To show efficacy of 17OH progesterone in prevention of preterm labor in comparison with frequent monitoring. Study Design: Randomized clinical trial. Place and Duration of Study: Department of Obstetrics and Gynecology, Combined Military Hospital Attock, from May 2011 to Dec 2011. M...

Full description

Bibliographic Details
Main Authors:	Rabia Sajjad, Chaudary Amjad Ali, Asma Ansari
Format:	Article
Language:	English
Published:	Army Medical College Rawalpindi 2020-08-01
Series:	Pakistan Armed Forces Medical Journal
Subjects:	17oh progesterone preterm labor
Online Access:	https://www.pafmj.org/index.php/PAFMJ/article/view/5090/2850

Similar Items

Progesterone supplementation for prevention of preterm labor: A randomized controlled trial
by: Moustafa Ibrahim, et al.
Published: (2010-01-01)

Addressing Decision Making in Progesterone Treatment for History of Preterm Delivery
by: Jacqueline Zuponcic, et al.
Published: (2019-07-01)

Prevention of Preterm Birth with Progesterone
by: Gian Carlo Di Renzo, et al.
Published: (2021-09-01)

Efficacy and safety of oral nifedipine with or without vaginal progesterone in the management of threatened preterm labor
by: Bushra Ashraf
Published: (2019-09-01)

Comparison of the duration of pregnancy in administration of progesterone suppository and Duphaston tablet in pregnant women with preterm labor after stopping delivery process
by: Marzieh Lotfalizadeh, et al.
Published: (2019-12-01)

Maintenance Therapy by Vaginal Progesterone after Threatened Idiopathic Preterm Labor: A Randomized Placebo-Controlled Double-blind Trial
by: Seyede Hajar Sharami, et al.
Published: (2010-07-01)

Vaginal versus intramuscular progesterone in the prevention of preterm labor and their effect on uterine and fetal blood flow
by: Azza A. Abd El Hameed
Published: (2012-09-01)

Effect of progesterone as maintenance tocolytic therapy on the prevention of recurrent preterm labor: a randomized clinical trial
by: Hajieh Borna, et al.
Published: (2007-03-01)

Comparison of Risk of Preterm Labor between Vaginal Progesterone and17-Alpha-Hydroxy-Progesterone Caproate in Women with Threatened Abortion: A Randomized Clinical Trial
by: Abootaleb Beigi, et al.
Published: (2016-07-01)

A Comparison between the Effects of Vaginal Suppository Progesterone vs. the Injection of 17-Alpha Hydroxyprogesterone Caproate on the Duration of Latent Phase After Controlled Threatened Preterm Labor
by: Fatemeh Mirzaei, et al.
Published: (2018-03-01)

Progesterone Receptor Signaling in the Uterus Is Essential for Pregnancy Success
by: Dominique I. Cope, et al.
Published: (2022-04-01)

Progesterone Gel and Placebo Prolonged Pregnancy More Effectively Than Intravenous Tocolysis Alone in Women with Preterm Labor
by: Ylva Vladic Stjernholm, et al.
Published: (2022-04-01)

Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
by: Stephanie M. Garcia, et al.
Published: (2021-07-01)

Development of progesterone electrospun nanofibers to coat Arabin pessaries as a dual preventive and therapeutic approach for preterm labor
by: Manal M. Almousained, et al.
Published: (2024-02-01)

Progesterone therapy for prevention of recurrent spontaneous preterm birth in a minority patient population: a retrospective study
by: Genevieve R. Mazza, et al.
Published: (2024-04-01)

Progesterone and the Latency Period: Threatened Preterm Labor
by: S Borna, et al.
Published: (2008-06-01)

Role of vaginal progesterone on uterine artery Doppler changes in pregnant women at risk of preterm labor
by: Ibrahim M El-Maghraby, et al.
Published: (2022-01-01)

Vaginal progesterone for prevention of preterm birth in asymptomatic high-risk women with a normal cervical length: a systematic review and meta-analysis protocol
by: Kimberley P. Williams, et al.
Published: (2021-05-01)

Perceived acceptability of progesterone to prevent preterm births and low birth weight among HIV-infected and HIV-uninfected Zambian pregnant women
by: Wong JMH, et al.
Published: (2017-11-01)

Effects of Progesterone on Latency Period in Patients with Preterm Premature Rupture of Membranes during 24-34 Weeks of Pregnancy
by: Fatemeh Mirzaei, et al.
Published: (2015-05-01)

Progesterone, cervical cerclage or cervical pessary to prevent preterm birth: a decision-making analysis of international guidelines
by: Putora Katharina, et al.
Published: (2022-04-01)

COMPARISON OF MICRONIZED PROGESTERONE (CYCLOGEST PESSARY) AND PLACEBO IN PREVENTION OF PRE-TERM BIRTH IN TERTIARY CARE HOSPITAL
by: Nighat Afridi, et al.
Published: (2020-12-01)

The effectiveness of vaginal progesterone in reducing preterm birth in high-risk patients diagnosed with short cervical length after 24 weeks: A retrospective cohort study
by: Danielle Luxenbourg, et al.
Published: (2023-03-01)

The role of salivary progesterone and cervical length measurement in predicting risk of spontaneous preterm birth
by: Sara Oday, et al.
Published: (2021-06-01)

Evaluation of risk factors and modern possibilities for prediction of preterm labour
by: A. O. Shevchenko, et al.
Published: (2019-12-01)

Effectiveness of 17-Alpha-Hydroxyprogesterone in the Prevention of Preterm Labour
by: Uzma Urooj, et al.
Published: (2023-03-01)

Maternal and Fetal Doppler Blood Flow Velocimetry Changes in the Management of Asymptomatic Preterm Labor With Vaginal Progesterone Tablet
by: Shirin Niromanesh, et al.
Published: (2018-06-01)

Oral dydrogesterone as an adjunctive therapy in the management of preterm labor: a randomized, double blinded, placebo‐controlled trial
by: Suparudeewan Thongchan, et al.
Published: (2021-01-01)

Effect of 17 α-Hydroxyprogesterone Caproate on the Prevention of Preterm Labor: A Randomized Controlled Trial Study
by: Hamed Jafarpour, et al.
Published: (2020-07-01)

Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial
by: Maud D. van Zijl, et al.
Published: (2017-09-01)

CONCENTRATIONS OF PROGESTERONE AND ESTRADIOL-17Β IN THE FOLLICULAR FLUID OF OVARIAN FOLLICLES OF GOAT
by: D. Supriyaraj, et al.
Published: (2017-01-01)

Comparing the efficacy of vaginal micronized progesterone gel and capsule for prevention of preterm birth in singleton pregnancies with short cervical length at midtrimester: an indirect comparison meta-analysis
by: Doron Kabiri, et al.
Published: (2023-07-01)

Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes
by: Fatemeh Abdali, et al.
Published: (2018-01-01)

A comparison of neonatal outcomes after taking progesterone pills and progesterone intramuscular injections in preterm labor: An RCT
by: Maryam Dalili, et al.
Published: (2023-08-01)

Micronized progesterone: several aspects of miscarriage prophylaxis
by: N A Osipova
Published: (2014-06-01)

17-α Hydroxyprogesterone Caproate Immunology, a Special Focus on Preterm Labor, Preeclampsia, and COVID-19
by: Rasha A. Al-Lami
Published: (2022-08-01)

Progesterone Inhibits Human Myometrial Contractions by Action on Membrane Receptors
by: Remzi Gokdeniz, et al.
Published: (2013-02-01)

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial
by: Joan T. Price, et al.
Published: (2019-02-01)

Serum Progesterone and Estradiol-17β Profiles in Nili Ravi Buffaloes (Bubalus bubalis) with and without Dystocia
by: Muhammad Amjad Ali, Laeeq Akbar Lodhi and Faiz-ul-Hassan1*
Published: (2012-10-01)

COMPARISON OF MICRONIZED PROGESTERONE (CYCLOGEST PESSARY) AND PLACEBO IN PREVENTION OF PRE-TERM BIRTH IN TERTIARY CARE HOSPITAL
by: Nighat Afridi, et al.
Published: (2020-12-01)